Clinical trials
Not yet recruiting Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 11 |
| 2025 | 22 |
| 2026 | 53 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 11 |
| Tianjin Medical University Cancer Institute and Hospital | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Harbin Medical University | 3 |
| Henan Cancer Hospital | 2 |
| Shanghai Henlius Biotech | 2 |
| Shengjing Hospital | 2 |
| The Netherlands Cancer Institute | 2 |
| Xijing Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 95 |
| Breast Neoplasms | 27 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colorectal Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Neoplasm Metastasis | 3 |
| Recurrence | 3 |
| Uterine Cervical Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.